Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polyarticular Juvenile Arthritis”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Early research (Phase 1)Study completedNCT04018599
What this trial is testing

Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS

Who this might be right for
Rheumatoid ArthritisPolyarticular Juvenile Idiopathic ArthritisPsoriatic Arthritis+8 more
Fresenius Kabi SwissBioSim GmbH 216
Post-approval studies (Phase 4)Study completedNCT07428551
What this trial is testing

Comparative Study of Leflunomide Plus Methotrexate Versus Methotrexate Monotherapy in Refractory Polyarticular Juvenile Idiopathic Arthritis Patients

Who this might be right for
Juvenile Idiopathic ArthritisPolyarticular Juvenile Idiopathic ArthritisRefractory Polyarticular Juvenile Idiopathic Arthritis
Bangladesh Medical University 50
Large-scale testing (Phase 3)Study completedNCT01667471
What this trial is testing

A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis Who Completed WA19977 Core Study

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 6
Large-scale testing (Phase 3)Study completedNCT02277444
What this trial is testing

Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy

Who this might be right for
Arthritis, Juvenile
Janssen Research & Development, LLC 130
Large-scale testing (Phase 3)Looking for participantsNCT03773965
What this trial is testing

Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Eli Lilly and Company 190
Large-scale testing (Phase 3)Study completedNCT01673919
What this trial is testing

A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis From France Who Completed WA19977 Core Study

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 7
Large-scale testing (Phase 3)Looking for participantsNCT06654882
What this trial is testing

Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis

Who this might be right for
Polyarticular Course Juvenile Idiopathic Arthritis (JIA)
Duke University 400
Large-scale testing (Phase 3)Study completedNCT02592434
What this trial is testing

Efficacy Study Of Tofacitinib In Pediatric JIA Population

Who this might be right for
Juvenile Idiopathic Arthritis
Pfizer 225
Not applicableStudy completedNCT00783510
What this trial is testing

Juvenile Idiopathic Arthritis (JIA) Registry

Who this might be right for
Juvenile Idiopathic ArthritisJIA
AbbVie 849
Large-scale testing (Phase 3)Study completedNCT00690573
What this trial is testing

Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis

Who this might be right for
Juvenile Rheumatoid Arthritis
Abbott 25
Large-scale testing (Phase 3)Study completedNCT01844518
What this trial is testing

Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)

Who this might be right for
Active Polyarticular Juvenile Idiopathic Arthritis
Bristol-Myers Squibb 219
Not applicableEnded earlyNCT01557452
What this trial is testing

Open-Label Extension of the Dose Finding Study (DSC/08/2357/36) in Patients With Poly Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Italfarmaco 1
Large-scale testing (Phase 3)Study completedNCT00144664
What this trial is testing

Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Chugai Pharmaceutical 19
Large-scale testing (Phase 3)Study completedNCT01727986
What this trial is testing

An Extension Long-Term Study of RoActemra/Actemra (Tocilizumab) in Patients With Polyarticular Juvenile Idiopathic Arthritis Who Completed The WA19977 Study

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 11
Large-scale testing (Phase 3)Study completedNCT02840175
What this trial is testing

Treatment Tapering in JIA With Inactive Disease

Who this might be right for
Juvenile Idiopathic Arthritis
Assistance Publique - Hôpitaux de Paris 62
Testing effectiveness (Phase 2)WithdrawnNCT06623240
What this trial is testing

HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis (JIA)
Hope Biosciences Research Foundation
Testing effectiveness (Phase 2)Study completedNCT02776735
What this trial is testing

An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)

Who this might be right for
Juvenile Idiopathic Arthritis
Sanofi 102
Large-scale testing (Phase 3)Ended earlyNCT03781375
What this trial is testing

Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis

Who this might be right for
Juvenile Rheumatoid Arthritis
Amgen 25
Large-scale testing (Phase 3)Study completedNCT00048542
What this trial is testing

Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)

Who this might be right for
Arthritis, Juvenile Idiopathic
Abbott 171
Large-scale testing (Phase 3)Ended earlyNCT01230827
What this trial is testing

The Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)

Who this might be right for
Juvenile Idiopathic Arthritis
Janssen Research & Development, LLC 173
Load More Results